Nov. 19POPLARVILLE Dr. James M. Riser said on Wednesday that about 500 school students here were vaccinated on Monday and Tuesday by health care officials, and that an additional round of vaccinations is planned for Dec. 14 to give students here another chance to get the swine flu shot. "We had hoped for at least 1,000, but it was still very s
ACM Global Central Laboratory, the global central lab that continually defines the customer-service standard with its flexible approach, is this week celebrating its 10th anniversary of providing central laboratory services throughout Europe.
3M Skin & Wound Care Division announced that the American Medical Association has created a new Category I Current Procedural Terminology (CPT) code that will describe the application of 3M Coban 2 Layer Compression System; CPT code 29581 - "Application of multi-layer venous wound compression system, below the knee."
Dublin - Research and Markets has announced the addition of the "Analyzing the Generic Drugs Sector of the US Pharmaceutical Industry" report to their offering. A generic drug is a copy that is the same as a brand-name drug in dosage, safety, strength, how it is taken, quality, performance and intended use.
Antares Pharma, Inc. announced that it will release its third quarter 2009 financial results after the market closes on Monday, November 9, 2009, and host a conference call shortly thereafter at 4:30 PM to discuss the results. Interested parties may participate in the conference call by dialing 1-800-762-8908, or 480-629-9774, 5-10 minutes prior
BD today announced the completion of its acquisition of HandyLab, Inc., an Ann Arbor, Michigan-based company that develops and manufactures molecular diagnostic assays and automation platforms.
Nov. 19County commissioner Wayne Willingham addressed West Point's town council Monday evening regarding the county's proposed Smith Lake water project. "This is a feasible proposal," Willingham said. The county's plan includes upgrading the treatment facilities at Lake Catoma and constructing a new treatment facility that would pump water from S
Complete Genomics, a third-generation human genome sequencing company, announced publication of a report in the journal Science describing its proprietary DNA sequencing platform, including analysis of sequence data from three complete human genomes.
SAS announced that Dainippon Sumitomo Pharma America, Inc., a U.S. pharmaceutical company, has selected SAS Solutions OnDemand: Drug Development as a technology platform for clinical development. The SAS OnDemand service has allowed DSPA to move quickly, with limited internal resources, in creating its centralized SAS development environment.
According to recent research published in the Journal of Cardiovascular Pharmacology, "The effect of carperitide, recombinant human atrial natriuretic peptide, on chronic heart failure has not been clarified. "A 28-day infusion of carperitide or vehicle was administrated to the rats 4 weeks after experimental autoimmune myocarditis induction.
Dendreon Corporation today announced that the U.S. Food and Drug Administration provided written acknowledgement that the Company's amended Biologics License Application for PROVENGE is a complete response. The FDA considers this to be a complete, Class 2 Resubmission following the action letter the company received in 2007.
Vince and Associates Clinical Research, a leading provider of Phase I-IV clinical research trials, announced that Dr. Bradley Vince, Medical Director and President, shared his expertise at the Exploratory Development World Congress on October 20, 2009 in Boston, Massachusetts.
Emerson Resources, Inc., a premier pharmaceutical solutions company, announced that it has formed a strategic partnership with Bio Research, a contract research organization that specializes in the agrichemical and related industries, to further extend its business development capabilities.
Eurogentec S.A. announces a final agreement for the acquisition of AnaSpec Inc, a privately held proteomics company based in Fremont, California. nies to enhance their diagnostic solutions. "Bringing AnaSpec into the Eurogentec Group is a strategic decision for our company," explains Jean-Pierre Delwart, CEO of Eurogentec. pec's products in the
preliminary opinion was announced in a press release issued last month. Antigenics Inc. today announced that the Committee for Medicinal Products for Human Use, the scientific committee of the European Medicines Agency, has formally adopted a negative opinion on the marketing authorization application for Oncophage as a treatment in earlier-stage,
A diverse group of health care and consumer organizations released five policy recommendations this week that are designed to promote better medication adherence and improved health outcomes for patients.
Revatio is the Only Treatment in Its Class with Both Oral and Intravenous Formulations. Pfizer announced today that the U.S. Food and Drug Administration has approved Revatio Injection, an intravenous formulation of Revatio. Revatio is indicated for the treatment of adult patients with pulmonary arterial hypertension to improve exercise ability and
CombinatoRx, Incorporated and Neuromed Pharmaceuticals Inc., a privately-held biopharmaceutical company, today announced that the U.S. Food and Drug Administration has issued Neuromed a letter extending its review of the New Drug Application for the product candidate Exalgo extended-release tablets by three months.
"The pharmacokinetics of good manufacturing process injection of artesunate were evaluated after single closes at 0.5, 1, 2.4, and 8 mg/kg with a 2-minute infusion in 40 healthy subjects. "The drug was immediately converted to dihydroartemisinin, with elimination half-lives ranging 0.12-0.24 and 1.15-2.37 hours for AS and DHA. respectively.
Guidance for Industry on Changes to Approved New Animal Drug ApplicationsNew Animal Drug Applications Versus Category II Supplemental New Animal Drug Applications; Availability. SUMMARY: The Food and Drug Administration is announcing the availability of a guidance for industry #191 entitled "Changes to Approved NADAsNew NADAs vs.
New Haven, Conn. With over 1,000 students, almost 2,000 faculty and a budget approaching $1 billion, the enterprise over which Alpern presides is by far the largest of the University's graduate programs. The Yale Bulletin & Calendar recently met with Alpern, who reflected on his first term at Yale and shared his vision for the future.
Data Presented at International Melanoma Conference in Berlin. Results Follow Decision by Company to Continue Phase 3 AGENDA Trial for Overall Survival.
Nov. 20The Greater Akron region has received enough H1N1 influenza vaccines to cover all residents at the highest risk of developing serious complications from the flu. So far, 73,350 vaccines have been shipped to health departments and other medical providers in Summit County, according to an analysis released Thursday by the Ohio Department of
